China grants patent to pSivida Limited

May 11, 2005 — Nanotechnology company pSivida Limited of Perth, Australia, today announced it has been granted its first patent in China, a key market for pSivida’s silicon implants. pSivida is in exploratory discussions with commercialization partners for the Chinese market for its implants that deliver drugs as they biodegrade in tissue.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.